A Study of [14C]-LY3537982 in Healthy Participants

NCT05901311 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3537982
DRUG: [¹⁴C]-LY3537982
DRUG: [¹⁴C]-LY3537982

Sponsor

Eli Lilly and Company

Collaborators

[object Object]